Caseware UK (AP4) 2023.0.135 2023.0.135 2023-11-302023-11-30true12022-12-011truetruefalse 12303437 2022-12-01 2023-11-30 12303437 2021-12-01 2022-11-30 12303437 2023-11-30 12303437 2022-11-30 12303437 c:Director1 2022-12-01 2023-11-30 12303437 d:CurrentFinancialInstruments 2023-11-30 12303437 d:CurrentFinancialInstruments 2022-11-30 12303437 d:CurrentFinancialInstruments d:WithinOneYear 2023-11-30 12303437 d:CurrentFinancialInstruments d:WithinOneYear 2022-11-30 12303437 d:ShareCapital 2023-11-30 12303437 d:ShareCapital 2022-11-30 12303437 d:RetainedEarningsAccumulatedLosses 2023-11-30 12303437 d:RetainedEarningsAccumulatedLosses 2022-11-30 12303437 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2023-11-30 12303437 d:FinancialAssetsDesignatedFairValueThroughProfitOrLoss 2022-11-30 12303437 c:EntityHasNeverTraded 2022-12-01 2023-11-30 12303437 c:FRS102 2022-12-01 2023-11-30 12303437 c:AuditExempt-NoAccountantsReport 2022-12-01 2023-11-30 12303437 c:FullAccounts 2022-12-01 2023-11-30 12303437 c:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30 12303437 e:PoundSterling 2022-12-01 2023-11-30 iso4217:GBP xbrli:pure

Registered number: 12303437










EDISON HEALTHCARE LIMITED








UNAUDITED

FINANCIAL STATEMENTS

INFORMATION FOR FILING WITH THE REGISTRAR

FOR THE YEAR ENDED 30 NOVEMBER 2023

 
EDISON HEALTHCARE LIMITED
REGISTERED NUMBER: 12303437

BALANCE SHEET
AS AT 30 NOVEMBER 2023

2023
2022
Note
£
£

  

Current assets
  

Cash at bank and in hand
 3 
100
100

  
100
100

Creditors: amounts falling due within one year
 4 
(1,560)
(780)

Net current liabilities
  
 
 
(1,460)
 
 
(680)

Total assets less current liabilities
  
(1,460)
(680)

  

Net liabilities
  
(1,460)
(680)


Capital and reserves
  

Called up share capital 
  
100
100

Profit and loss account
  
(1,560)
(780)

  
(1,460)
(680)


Page 1

 
EDISON HEALTHCARE LIMITED
REGISTERED NUMBER: 12303437
    
BALANCE SHEET (CONTINUED)
AS AT 30 NOVEMBER 2023

For the year ended 30 November 2023 the company was entitled to exemption from audit under section 480 of the Companies Act 2006.

Members have not required the company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 




S Patel
Director

Date: 16 August 2024

The notes on pages 3 to 5 form part of these financial statements.

Page 2

 
EDISON HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023

1.


General information

Edison Healthcare Limited is a private company limited by share, incorporated in the United Kingdom and registered in England and Wales. The principle place of business is Bessemer Cresent, Rabans Lane Industrial, Aylesbury, Bucks, HP19 8TF.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

 
2.2

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
2.3

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

 
2.4

Financial instruments

The company has elected to apply the provisions of Section 11 “Basic Financial Instruments” of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's Balance sheet when the company becomes party to the contractual provisions of the instrument.

Basic financial assets

Basic financial assets, which include trade and other receivables, cash and bank balances, are initially measured at their transaction price including transaction costs and are subsequently carried at their amortised cost using the effective interest method, less any provision for impairment, unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest.

Discounting is omitted where the effect of discounting is immaterial. The company's cash and cash equivalents, trade and most other receivables due with the operating cycle fall into this category of financial instruments.

Other financial assets

Other financial assets, which includes investments in equity instruments which are not classified as subsidiaries, associates or joint ventures, are initially measured at fair value, which is normally the recognised transaction price. Such assets are subsequently measured at fair value with the changes in fair value being recognised in the profit or loss. Where other financial assets are not publicly traded, hence their fair value cannot be measured reliably, they are measured at cost less
Page 3

 
EDISON HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023

2.Accounting policies (continued)


2.4
Financial instruments (continued)

impairment.

Financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instruments any contract that evidences a residual interest in the assets of the company after the deduction of all its liabilities.

Basic financial liabilities, which include trade and other payables, bank loans and other loans are initially measured at their transaction price after transaction costs. When this constitutes a financing transaction, whereby the debt instrument is measured at the present value of the future receipts discounted at a market rate of interest. Discounting is omitted where the effect of discounting is immaterial.

Debt instruments are subsequently carried at their amortised cost using the effective interest rate method.

Trade payables are obligations to pay for goods and services that have been acquired in the ordinary course of business from suppliers. Trade payables are classified as current liabilities if the payment is due within one year. If not, they represent non-current liabilities. Trade payables are initially recognised at their transaction price and subsequently are measured at amortised cost using the effective interest method. Discounting is omitted where the effect of discounting is immaterial.

Derecognition of financial assets

Financial assets are derecognised when their contractual right to future cash flow expire, or are settled, or when the company transfers the asset and substantially all the risks and rewards of ownership to another party. If significant risks and rewards of ownership are retained after the transfer to another party, then the company will continue to recognise the value of the portion of the risks and rewards retained.

Derecognition of financial liabilities

Financial liabilities are derecognised when the company's contractual obligations expire or are discharged or cancelled.


3.


Cash and cash equivalents

2023
2022
£
£

Cash at bank and in hand
100
100

100
100


Page 4

 
EDISON HEALTHCARE LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 NOVEMBER 2023

4.


Creditors: Amounts falling due within one year

2023
2022
£
£

Other creditors
960
360

Accruals and deferred income
600
420

1,560
780



5.


Financial instruments

2023
2022
£
£

Financial assets


Financial assets measured at fair value through profit or loss
100
100




Financial assets measured at fair value through profit or loss comprise of cash and cash equivalents.


6.


Controlling party

The company was controlled throughout the year by S Patel by virtue of their shareholding.

 
Page 5